Company Data
Capstone Holding Corp
Ticker
CAPS
Current Price
$4.1
Market Cap
$223.0M
Price Target
Refer to Report
Volume
1
52wk Range
$4.1 - $7.5
Overview
Capstone Holding Corp formerly Capstone Therapeutics Corp is a biotechnology company, which develops a pipeline of novel therapeutic peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs for the treatment of Homozygous Familial Hypercholesterolemia, other hyperlipidemic indications, and acute coronary syndrome/atherosclerosis regression.